Objective To report outcomes on patients with multiple sclerosis (MS) and related disorders
with coronavirus disease 2019 (COVID-19) illness. Methods From March 16 to April 30, 2020…

The North American Research Committee on Multiple Sclerosis (NARCOMS) Registry is a
database that contains information from over 35,000 patient volunteers on symptom severity …

Objective: To create a reference table of disability outcomes in multiple sclerosis (MS) that
would enable patients to rank their disability relative to others' with similar disease duration …

Since its initial reports in the 19th century, neuromyelitis optica (NMO) had been thought to
involve only the optic nerves and spinal cord. However, the discovery of highly specific anti–…

Background High-efficacy therapies in multiple sclerosis are traditionally used after
unsuccessful treatment with first-line disease modifying therapies. We hypothesised that early …

Objective To use the large dataset from the Tysabri Outreach: Unified Commitment to Health
(TOUCH) program to compare progressive multifocal leukoencephalopathy (PML) risk with …

We describe a young woman with localized scleroderma, seizures, numerous persistently
enhancing white matter lesions on brain MRI, and oligoclonal bands in the CSF. The case is …

The objectives of this study were: (1) to assess relative frequency of migraine in multiple
sclerosis (MS) patients using the validated self-administered diagnostic questionnaire, and to …

Whether disease course in Hispanic Americans (HA) with multiple sclerosis (MS) is different
from Caucasian Americans (CA) or African Americans (AA) is unknown. We compared MS …

Background Discontinuation of injectable disease-modifying therapy (DMT) for multiple
sclerosis (MS) after a long period of relapse freedom is frequently considered, but data on post-…